Overlapping and Distinct FAS/FASLG Gene Polymorphisms in Alopecia Areata in an Iranian Population

References

• Akatsu T, Nakamura M, Satoh M, Hiramori K. 2003. Increased mRNA expression of tumour necrosis factor-alpha and its converting enzyme in circulating leucocytes of patients with acute myocardial infarction. Clin Sci (Lond). 105:39–44.
   PubMed Web of Science ®Google Scholar
• Betz RC, Petukhova L, Ripke S, Huang H, Menelaou A, Redler S, Becker T, Heilmann S, Yamany T, Duvic M, et al. 2015. Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun. 6:5966.
   PubMed Web of Science ®Google Scholar
• Biran R, Zlotogorski A, Ramot Y. 2015. The genetics of alopecia areata: new approaches, new findings, new treatments. J Dermatol Sci. 78:11–20.
   PubMed Web of Science ®Google Scholar
• Blaumeiser B, van der Goot I, Fimmers R, Hanneken S, Ritzmann S, Seymons K, Betz RC, Ruzicka T, Wienker TF, De Weert J, et al. 2006. Familial aggregation of alopecia areata. J Am Acad Dermatol. 54:627–32.
   PubMed Web of Science ®Google Scholar
• Bodemer C, Peuchmaur M, Fraitaig S, Chatenoud L, Brousse N, De Prost Y. 2000. Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol. 114:112–16.
   PubMed Web of Science ®Google Scholar
• Botchkareva NV, Ahluwalia G, Shander D. 2006. Apoptosis in the hair follicle. J Invest Dermatol. 126:258–64.
   PubMed Web of Science ®Google Scholar
• Chen L, Duan H, Xie F, Gao Z, Wu X, Chen F, Wu W. 2018. Tetrahydroxystilbene glucoside effectively prevents apoptosis induced hair loss. Biomed Res Int. 2018:1380146.
   PubMedGoogle Scholar
• Dianzani U, Chiocchetti A, Ramenghi U. 2003. Role of inherited defects decreasing Fas function in autoimmunity. Life Sci. 72:2803–24.
   PubMed Web of Science ®Google Scholar
• Fan X, Shangguan L, Li M, Li CY, Liu B. 2010. Functional polymorphisms of the FAS/FASLG genes are associated with risk of alopecia areata in a Chinese population: a case-control analysis. Br J Dermatol. 163:340–44.
   PubMed Web of Science ®Google Scholar
• Freyschmidt-Paul P, McElwee KJ, Botchkarev V, Kissling S, Wenzel E, Sundberg JP, Happle R, Hoffmann R. 2003. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice. J Investig Dermatol Symp Proc. 8:104–08.
   PubMed Web of Science ®Google Scholar
• Ghaderian SM, Akbarzadeh Najar R, Tabatabaei Panah AS. 2011. Tumor necrosis factor-alpha: investigation of gene polymorphism and regulation of TACE-TNF-alpha system in patients with acute myocardial infarction. Mol Biol Rep. 38:4971–77.
   PubMed Web of Science ®Google Scholar
• Gilhar A, Schrum AG, Etzioni A, Waldmann H, Paus R. 2016. Alopecia areata: animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies. Autoimmun Rev. 15:726–35.
   PubMed Web of Science ®Google Scholar
• Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1189–92.
   PubMed Web of Science ®Google Scholar
• Huang D, Xiao J, Deng X, Ma K, Liang H, Shi D, Wu F, Shao Z. 2018. Association between Fas/FasL gene polymorphism and musculoskeletal degenerative diseases: a meta-analysis. BMC Musculoskelet Disord. 19:137.
   PubMed Web of Science ®Google Scholar
• Kalkan G, Ates O, Karakus N, Sezer S. 2013. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of alopecia areata. Arch Dermatol Res. 305:909–15.
   PubMed Web of Science ®Google Scholar
• Kemp EH, McDonagh AJ, Wengraf DA, Messenger AG, Gawkrodger DJ, Cork MJ, Tazi-Ahnini R. 2006. The non-synonymous C1858T substitution in the PTPN22 gene is associated with susceptibility to the severe forms of alopecia areata. Hum Immunol. 67:535–39.
   PubMed Web of Science ®Google Scholar
• Kim MH, Kim SH, Yang WM. 2014. Beneficial effects of Astragaloside IV for hair loss via inhibition of Fas/Fas L-mediated apoptotic signaling. PLoS One. 9:e92984.
   PubMed Web of Science ®Google Scholar
• Mohammadzadeh A, Pourfathollah AA, Tahoori MT, Daneshmandi S, Langroudi L, Akhlaghi M. 2012. Evaluation of apoptosis-related gene Fas (CD95) and FasL (CD178) polymorphisms in Iranian rheumatoid arthritis patients. Rheumatol Int. 32:2833–36.
   PubMed Web of Science ®Google Scholar
• Moravvej H, Tabatabaei-Panah PS, Abgoon R, Khaksar L, Sokhandan M, Tarshaei S, Ghaderian SMH, Ludwig RJ, Akbarzadeh R. 2018a. Genetic variant association of PTPN22, CTLA4, IL2RA, as well as HLA frequencies in susceptibility to alopecia areata. Immunol Invest. 47:666–79.
   PubMed Web of Science ®Google Scholar
• Moravvej H, Tabatabaei-Panah PS, Ebrahimi E, Esmaeili N, Ghaderian SMH, Ludwig RJ, Akbarzadeh R. 2018b. TNF-alpha −308G/A gene polymorphism in bullous pemphigoid and alopecia areata. Hum Antibodies. 26:201–07.
   PubMedGoogle Scholar
• Moudi B, Salimi S, Farajian Mashhadi F, Sandoughi M, Zakeri Z. 2013. Association of FAS and FAS ligand genes polymorphism and risk of systemic lupus erythematosus. ScientificWorldJournal. 2013:176741.
   PubMedGoogle Scholar
• Nagata S. 1999. Fas ligand-induced apoptosis. Annu Rev Genet. 33:29–55.
   PubMed Web of Science ®Google Scholar
• Oh JW, Kloepper J, Langan EA, Kim Y, Yeo J, Kim MJ, Hsi TC, Rose C, Yoon GS, Lee SJ, et al. 2016. A guide to studying human hair follicle cycling in vivo. J Invest Dermatol. 136:34–44.
   PubMed Web of Science ®Google Scholar
• Petukhova L, Christiano AM. 2016. Functional interpretation of genome-wide association study evidence in alopecia areata. J Invest Dermatol. 136:314–17.
   PubMed Web of Science ®Google Scholar
• Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, Kim H, Singh P, Lee A, Chen WV, et al. 2010. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature. 466:113–17.
   PubMed Web of Science ®Google Scholar
• Rajabi F, Amoli MM, Robati RM, Almasi-Nasrabadi M, Jabalameli N, Moravvej H. 2019. The association between genetic variation in Wnt transcription factor TCF7L2 (TCF4) and alopecia areata. Immunol Invest. 23:1–8.
   Google Scholar
• Rehman S, Saba N, Naz M, Ahmed P, Munir S, Sajjad S, Tabassum S, Naseem L. 2018. Single-nucleotide polymorphisms of FAS and FASL genes and risk of idiopathic aplastic anemia. Immunol Invest. 47:484–91.
   PubMed Web of Science ®Google Scholar
• Sarig O, Bercovici S, Zoller L, Goldberg I, Indelman M, Nahum S, Israeli S, Sagiv N, Martinez de Morentin H, Katz O, et al. 2012. Population-specific association between a polymorphic variant in ST18, encoding a pro-apoptotic molecule, and pemphigus vulgaris. J Invest Dermatol. 132:1798–805.
   PubMed Web of Science ®Google Scholar
• Seleit I, Bakry OA, Gayed EA, Gawad AE. 2018. Polymorphism of FAS and FAS ligand genes in alopecia areata: a case-control study in Egyptian population. Indian J Dermatol. 63:220–26.
   PubMed Web of Science ®Google Scholar
• Sharma K, Wang RX, Zhang LY, Yin DL, Luo XY, Solomon JC, Jiang RF, Markos K, Davidson W, Scott DW, et al. 2000. Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol Ther. 88:333–47.
   PubMed Web of Science ®Google Scholar
• Sibley K, Rollinson S, Allan JM, Smith AG, Law GR, Roddam PL, Skibola CF, Smith MT, Morgan GJ. 2003. Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res. 63:4327–30.
   PubMed Web of Science ®Google Scholar
• Suda T, Nagata S. 1997. Why do defects in the Fas-Fas ligand system cause autoimmunity? J Allergy Clin Immunol. 100:S97–101.
   PubMed Web of Science ®Google Scholar
• Suvannavejh GC, Dal Canto MC, Matis LA, Miller SD. 2000. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. J Clin Invest. 105:223–31.
   PubMed Web of Science ®Google Scholar
• Szymanski L, Cios A, Lewicki S, Szymanski P, Stankiewicz W. 2018. Fas/FasL pathway and cytokines in keratinocytes in atopic dermatitis - Manipulation by the electromagnetic field. PLoS One. 13:e0205103.
   PubMed Web of Science ®Google Scholar
• Tobin DJ. 2003. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J Investig Dermatol Symp Proc. 8:176–81.
   PubMedGoogle Scholar
• Villa-Morales M, Gonzalez-Gugel E, Shahbazi MN, Santos J, Fernandez-Piqueras J. 2010. Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility. Carcinogenesis. 31:2165–71.
   PubMed Web of Science ®Google Scholar
• Villasante Fricke AC, Miteva M. 2015. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol. 8:397–403.
   PubMed Web of Science ®Google Scholar
• Yildir S, Sezgin M, Barlas IO, Turkoz G, Ankarali HC, Sahin G, Erdal ME. 2013. Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis. Rheumatol Int. 33:2637–45.
   PubMedGoogle Scholar
• Yoo YG, Lee MO. 2004. Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor. J Biol Chem. 279:36242–49.
   PubMed Web of Science ®Google Scholar